RPTH will no longer have an active presence on X. While this account will remain available as an archive, we will no longer post new content or monitor comments
RPTH will no longer have an active presence on X. While this account will remain available as an archive, we will no longer post new content or monitor engagement. To continue receiving updates, follow us on:
LinkedIn: https://t.co/D9IXjs1v5j
BlueSky: https://t.co/TXuSgGRUH6
Hormonal changes during perimenopause can lead to a variety of symptoms - how best to manage while considering #thrombosis risk? 🤷♀️
This excellent State-of-the-Art review by by Briony A. Cutts and Kristy Fennessy offers insight into this clinical scenario.
https://t.co/h6oBT0uVQW
How do you manage bleeding risk in patients on oral anticoagulants for oral surgery? 🦷
This study from Isabelle Mahe and team suggests a short DOAC discontinuation before the invasive dental procedure can minimize bleeding!
https://t.co/v9u5qjUlHs
Vitamin K Deficiency is common in children with cholestatic liver disease. This excellent meta-analysis and review provides updates on the best way to supplement with Vitamin K.
https://t.co/F5ALX6nV1n
@Sirachainan#bleeding#hemostasis
Do you use viscoelastic testing to diagnose and treat bleeding disorders?
This study from Robert Frick and team compared two different ROTEM methods - delta and sigma - on healthy controls and various patient samples.
Check it out! https://t.co/z4R9EuS697
Does body composition influence responses to dexamethasone in cases of ITP? 🩸
Check out this report from Tyler Everhardt and team on platelet levels following Dexamethasone treatment: https://t.co/reEdSTBxoy
In this Case Report, Dr. Sarah Schober presents a rare case of combined inheritance of #Hemophilia A and Severe Combined #Immunodeficiency.
Hematopoietic Stem Cell Transplant was performed. This contributes to limited reports available on HSCT in SCID + HA.
https://t.co/c3yYZnAcrP
In 62 women on antepartum low-dose and postpartum high-dose thromboprophylaxis, this study reports:
6.56% major PPH
3.33% VTE
30.6% treatment modification.
Balancing VTE risk with adverse events like bleeding remains crucial. @seanrivrud
https://t.co/4hrrL0Rvx9
Joints frequently suffer the impact of the pathology of #Hemophilia. 💪
This cross-sectional multicenter study shows how diagnosing and managing arthropathy can improve QOL for individuals with hemophilia.
https://t.co/Qzt1nK1U9v
Wonderful @isth memory. I’m so grateful for the opportunities provided by ISTH for my own career development and for all the people in this photo from an @RPTHjournal celebration at the Montreal Congress!
See you in Washington DC in June
New treatment for Hemophilia B? 🩸
Trenonacog alfa is a recombinant factor IX approved for adolescents and adults with hemophilia B, and this update on its safety and efficacy is very promising!
https://t.co/6Z4ueseEsl
Using AI in Scientific Research! 👩💻
This study by @DeepaArachchil1 compares 7 different AI models to predict VTE risk in Covid-19 patients.
Read more about it: https://t.co/ENk6UyDr26
#artificialintelligence#covid#thrombosis
A new player in platelet regulation?
Chao He and team identify ERp18, a thiol isomerase, that contributes to adhesion molecule regulation, activation and thrombosis.
Read more here: https://t.co/bGR0V9PBS9
Don't be fooled by Antiphospholipid Syndrome (APS)!
Check out this Forum from Deepa Arachchillage and Mike Laffan about managing APS
https://t.co/UFDAQKb19r
@ProfMakris@AgustinRgzAlen@RPTHjournal Congratulations. Excellent editorial! Finally, treatment choice is personalized, and in all countries we should have options to choose from, also considering patient preferences.
Incredible: https://t.co/8MzDczXgMq. This was produced 100% by AI. It is entirely based on the editorial by me and @Brianhemophilia published in @RPTHjournal. It is 21 min and remarkably accurate. Thank you, Eugene Fan, for showing me what is possible.
Congratulations to the 2025 @RPTHjournal Editor’s Awards Winners! 🏆These awards recognize outstanding contributions from early career researchers whose work demonstrates excellence and impact. Join us in celebrating this year’s honorees!
📖 Read more: https://t.co/WbCDg3QaEr
Check out this new study on clots and fibrinolysis ✂️
Rebecca Risman and team report that clot density influences fibrinolysis: An important consideration for different disease states!
https://t.co/vZIp4DEWTO